Hydrazones and analogs as cholesterol lowering agents
US6605615B2 · kind B2 · utility
50Cited by
2References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 1, 2001 |
| Grant date | Aug 12, 2003 |
| Priority date | — |
| Expiry date | Mar 1, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Hydrazones and hydrazone analogs are provided which are useful as upregulators of LDL receptors and can be used in the treatment of hypercholesterolemia and related disorders and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.